title: Meeting report VLPNPV: Session 10: Virus-like particle and nano-particle vaccines.
abstract: Session 10 of the Virus-like Particle and Nano-Particle Vaccines meeting 2014 focused on new methods in vaccine technology to accelerate process development, manufacturing and quality control. The session presented new ways of quantifying and characterizing particle samples. In addition platform approaches for production and purification of virus-like particle (VLP) vaccines were highlighted.
authors.affiliation: a Karlsruhe Institute of Technology; Institute of Process Engineering in Life Sciences; Section IV: Biomolecular Separation Engineering ; Engler-Bunte-Ring , Karlsruhe.
authors.forename: Christopher Ladd
authors.initials: CL
authors.lastname: Effio
authors.forename: Juergen
authors.initials: J
authors.lastname: Hubbuch
mesh_terms: D000939:Epitopes / Q000276:immunology; D006801:Humans; D007252:Influenza Vaccines / Q000276:immunology*; D007251:Influenza, Human / Q000517:prevention & control; D017780:Malaria Vaccines / Q000276:immunology*; D016778:Malaria, Falciparum / Q000276:immunology / Q000517:prevention & control; D053758:Nanoparticles; D010963:Plasmodium falciparum / Q000276:immunology; D022261:Respiratory Syncytial Virus Vaccines / Q000276:immunology*; D012136:Respiratory Syncytial Viruses / Q000276:immunology; D058425:Vaccines, Virus-Like Particle / Q000276:immunology* / Q000627:therapeutic use*
chemical_list: D000939:Epitopes; D007252:Influenza Vaccines; D017780:Malaria Vaccines; D022261:Respiratory Syncytial Virus Vaccines; D058425:Vaccines, Virus-Like Particle
keywords: analytics; high-throughput screening; influenza; particle characterization; purification